NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve ...
23h
Since January 2024, pharmacists have been able to treat seven common health conditions without a prescription. The NHS have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback